Equities Analysts Set Expectations for PAHC FY2025 Earnings

Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) - Zacks Research raised their FY2025 earnings estimates for shares of Phibro Animal Health in a research report issued to clients and investors on Tuesday, December 10th. Zacks Research analyst R. Department now expects that the company will post earnings of $1.47 per share for the year, up from their previous forecast of $1.46. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2025 earnings at $0.42 EPS, Q1 2026 earnings at $0.30 EPS, FY2026 earnings at $1.61 EPS, Q1 2027 earnings at $0.47 EPS and FY2027 earnings at $2.11 EPS.

Several other equities research analysts also recently weighed in on PAHC. StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research note on Friday, December 6th. Barclays upped their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research note on Tuesday, November 12th. Bank of America upped their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research note on Friday, August 30th. Finally, JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price objective on the stock.

Phibro Animal Health Trading Down 0.3 %

Shares of Phibro Animal Health stock traded down $0.08 on Thursday, reaching $23.88. The company had a trading volume of 172,564 shares, compared to its average volume of 157,446. The firm's 50 day moving average price is $23.52 and its two-hundred day moving average price is $20.50. The firm has a market cap of $967.21 million, a PE ratio of 55.98, a PEG ratio of 0.60 and a beta of 0.51. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Institutional Trading of Phibro Animal Health

Several hedge funds have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD increased its holdings in shares of Phibro Animal Health by 7.4% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company's stock valued at $200,000 after purchasing an additional 1,063 shares in the last quarter. CWM LLC increased its holdings in shares of Phibro Animal Health by 89.8% in the 2nd quarter. CWM LLC now owns 2,188 shares of the company's stock valued at $37,000 after purchasing an additional 1,035 shares in the last quarter. Summit Securities Group LLC purchased a new position in shares of Phibro Animal Health in the 2nd quarter valued at about $83,000. Acadian Asset Management LLC increased its holdings in shares of Phibro Animal Health by 6.3% in the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock valued at $12,027,000 after purchasing an additional 42,299 shares in the last quarter. Finally, American Century Companies Inc. increased its holdings in Phibro Animal Health by 119.6% during the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock valued at $5,822,000 after acquiring an additional 189,068 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a dividend yield of 2.01%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health's dividend payout ratio (DPR) is presently 111.63%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.